Clinical Trials Logo

Clinical Trial Summary

Up to one-third of patients with myotonic dystrophy type 1 die suddenly mainly from arrhythmias. Sleep apnea is prevalent in myotonic dystrophy (DM1) patients. Among the serious complications from sleep apnea, the most alarming are arrhythmias and sudden cardiac death (SCD). Diagnosis of sleep apnea using simple tools in ambulatory cardiology practice may improve therapy of cardiac arrhythmias in patients with DM1


Clinical Trial Description

Obstructive sleep apnea (OSA) and central sleep apnea (CSA), the most common form of sleep disordered breathing (SDB), are prevalent in patients with myotonic dystrophy type 1 (DM1). Among the serious complications from sleep apnea, the most alarming are cardiovascular, including arrhythmias and sudden cardiac death (SCD). Diagnosis of SDB using simple tools in ambulatory cardiology practice may lead to an important primary or additional therapy to supplement the use of drugs or devices in the treatment of cardiac arrhythmias.

We hypothesize that DM1 patients with severe oxygen desaturations (Oxygen desaturation index >15/hour of sleep and/or cumulative time spent below 90% of SaO2 above 5% of time of recording) will exhibit three fold more nocturnal arrhythmias compared to DM1 group without oxygen desaturations during sleep.

During this project we will address the following aims:

- Is there a relationship between the severity of oxygen desaturations during sleep and nocturnal arrhythmias? We will address this question in a prospective study with seven nights of at home recordings with a multimodal holter EKG assessing together arrhythmias, thoracic impedance (in order to estimate respiratory movements) and SaO2.

- The specific proarrhythmic role of REM sleep will be assessed during a single night full polysomnography and multiple sleep latency tests (MSLT). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02375087
Study type Observational
Source University Hospital, Grenoble
Contact
Status Completed
Phase
Start date May 20, 2014
Completion date July 1, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT04624750 - Open Label Study in Adolescents and Children With Myotonic Disorders Phase 3
Recruiting NCT00082108 - Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
Recruiting NCT05890833 - The Risk of Falls Index for Patients With Neuromuscular Disorders
Completed NCT05027269 - Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients Phase 1/Phase 2
Completed NCT00233519 - Effects of SomatoKine (Iplex)Recombinant Human Insulin-like Growth Factor-1/Recombinant Human Insulin-like Growth Factor-binding Protein-3 (rhIGF-I/rhIGFBP-3) in Myotonic Dystrophy Type 1 (DM1) Phase 1/Phase 2
Completed NCT00167609 - Efficacy and Safety of DHEA for Myotonic Dystrophy Phase 2/Phase 3
Recruiting NCT06411288 - Global Study of Del-desiran for the Treatment of DM1 Phase 3
Recruiting NCT04003363 - The United Kingdom National Registry for Myotonic Dystrophy
Completed NCT01136330 - DM1 Heart Registry - DM1 Respiratory Registry N/A
Completed NCT01406873 - Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1 Phase 2
Completed NCT03959189 - Safety, Tolerability and Pharmacokinetics of ERX-963 in Adults With Myotonic Dystrophy Type 1 Phase 1
Completed NCT01931644 - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Recruiting NCT00127582 - RAMYD Study - Evaluation of Arrhythmic Risk in Myotonic Dystrophy Phase 3
Recruiting NCT02398786 - Myotonic Dystrophy Family Registry
Recruiting NCT05019625 - Biomarker Development for Muscular Dystrophies
Recruiting NCT05020002 - Extracellular RNA Biomarkers of Myotonic Dystrophy
Active, not recruiting NCT04616807 - An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders
Active, not recruiting NCT05479981 - Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients Phase 2
Terminated NCT02315339 - European Home Mechanical Ventilation Registry
Not yet recruiting NCT06147414 - Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders